Consistently, Creighton C.J. et al. showed that ERα+ PgR− BC cell lines overexpressing EGFR or constitutively active erbB-2 or RAF have a significantly lower expression of the ESR1 gene [50]. The gene discussed is ERBB2; the disease is breast cancer.